Next Wave in DNA Sequencing Market

Sequencing by synthesis (SBS), is one of the most influential and greatly adopted DNA sequencing technologies used by researchers and scientist globally. This technology offers a massive sequence throughput at modest costs in a single sequencing run.

DNA Sequencing Market was valued at $5,156 million in 2016 and is expected to reach $18,284 million in 2023, registering a CAGR of 19.6% from 2017 to 2023. DNA sequencing is a technology in which several DNA strands could be sequenced through massive parallelization. This sequencing includes both Sanger’s method of sequencing and non-Sanger’s methods of sequencing. Low cost, high accuracy and speed, and precise results even from low sample input are the main advantages DNA sequencing offers over microarray and other genomic analysis methods.

DNA sequencing is used to execute various applications, such as biomarker discovery, oncology studies, personalized medicine, forensics, and others. It has streamlined nucleotide analysis and consist of widely replaced conventional tools of genomics, especially microarray, genotyping, and others. The demand for DNA sequencing has increased significantly, owing to surge in sequencing applications and rise in technological advancements in DNA sequencing. In addition, the growth in number of genome mapping programs globally and increase in R&D investment drive the market growth.

Access Full Summary at : https://www.alliedmarketresearch.com/dna-sequencing-market

The DNA sequencing market is segmented based on product, application, technology, end user, and geography. Based on product, it is classified into consumable, instrument, and service. The consumables segment occupied dominant share in 2016, and is expected to maintain this trend during the forecast period. This is attributed to the fact that they are widely used throughout the sample preparation process and are needed to perform other pre-requisite steps of DNA sequencing.

Asia-Pacific possesses high market potential for the growth of DNA sequencing market, owing to increase in awareness about DNA sequencing, rise in DNA sequencing applications, and others. This region is anticipated to experience fast-paced growth, in terms of development and use of DNA sequencing technologies.

The key players operating in the global DNA sequencing market include Illumina, Inc., Thermo Fisher Scientific, Inc., Siemens AG, Pacific Biosciences of California, Inc., ZS Genetics, Inc., Beckman Coulter (Fullerton, CA), 454 Life Sciences Corporation (Roche Holding AG), Agilent Technologies, Inc., Abbott Laboratories, and LI-COR, Inc.

The other prominent players in the value chain include Eurofins Scientific, Gatc Biotech AG, Macrogen, Inc., Oxford Nanopore Technologies, Ltd., Bio-Rad Laboratories, Inc., DNASTAR, Inc., Biomatters Ltd., New England Biolabs, Inc., and Myriad Genetics, Inc.

At present, the biomarkers and cancer segment dominate the application segment and is expected to grow at a CAGR of 18.9%. DNA sequencing possesses the potential to recognize a broad spectrum of genetic differences and supplement the generation of potent biomarkers in medicine and disease diagnostics. In addition, sequencing time, protocol length, declining cost of DNA sequencing make it an ideal technology for biomarker discovery.

Get Sample PDF Brochure : https://www.alliedmarketresearch.com/request-sample/163

Key Findings of the DNA Sequencing Market:
• The instrument product segment is anticipated to grow at the highest CAGR from 2017 to 2023.
• The personalized medicine application segment is expected to witness the highest growth rate during the forecast period.
• The academic and government research institutes segment generated the highest revenue in 2016, and is expected to continue its dominance in the future as well.
• North America dominated the global DNA sequencing market, and is projected to grow at a CAGR of 18.7%.
• Pyrosequencing technology is expected to witness the highest growth rate during the forecast period.

Allied Market Research (AMR) is a full-service market research and business-consulting wing of Allied Analytics LLP based in Portland, Oregon. Allied Market Research provides global enterprises as well as medium and small businesses with unmatched quality of "Market Research Reports" and "Business Intelligence Solutions.” AMR has a targeted view to provide business insights and consulting to assist its clients to make strategic business decisions and achieve sustainable growth in their respective market domain.
We are in professional corporate relations with various companies and this helps us in digging out market data that helps us generate accurate research data tables and confirms utmost accuracy in our market forecasting. Each and every data presented in the reports published by us is extracted through primary interviews with top officials from leading companies of domain concerned. Our secondary data procurement methodology includes deep online and offline research and discussion with knowledgeable professionals and analysts in the industry.

Shriram Dighe
5933 NE Win Sivers Drive
#205, Portland, OR 97220
United States
Toll Free: +1-800-792-5285
UK: +44-845-528-1300
Hong Kong: +852-301-84916
India (Pune): +91-20-66346060
Fax: +1⟨855⟩550-5975
help@alliedmarketresearch.com
Web: https://www.alliedmarketresearch.com

This release was published on openPR.